HopeStage
Back to all studies
RecruitingNCT06719427

EEG brain activity during magnetic stimulation for treatment-resistant depression

About this titleRead the official source — NCT06719427
Device studyAges 18–80Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

Listed locations
North York and 1 more locationSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 6, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
100
Sponsor
Sunnybrook Health Sciences Centre
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
Canada
Age range
From 18 Years to 80 Years
Official registry ID
NCT06719427
Official title
Show the full official title

Quantitative Electroencephalography to Longitudinally Assess the Functional Brain Signature of Treatment-resistant Depression and Recovery With Therapeutic Neuromodulation

Recruitment & locations

Currently recruiting

North York · Toronto

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunnybrook Health Sciences Centre.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies